Akari Therapeutics
AKTX
12 hedge funds and large institutions have $3.9M invested in Akari Therapeutics in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
33% more capital invested
Capital invested by funds: $2.93M → $3.9M (+$967K)
0% more funds holding
Funds holding: 12 → 12 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$86.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$79.3K |
| 3 |
OFW
Omnia Family Wealth
Aventura,
Florida
|
+$72.5K |
| 4 |
Renaissance Technologies
New York
|
+$70.3K |
| 5 |
HF
HRT Financial
New York
|
+$45.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$382K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$49K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| 4 |
TC
Truvestments Capital
Sarasota,
Florida
|
-$2.27K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NMC
1
NEA Management Company
Timonium,
Maryland
| $1.19M | – | – | – |
|
|
OFW
2
Omnia Family Wealth
Aventura,
Florida
| $1.1M | +$72.5K | +32 | +7% |
|
|
UAS
3
United Asset Strategies
Garden City,
New York
| $765K | +$9.07K | +4 | +1% |
|
|
4
Renaissance Technologies
New York
| $350K | +$70.3K | +31 | +23% |
|
|
HP
5
Hikari Power
Tokyo,
Japan
| $237K | – | – | – |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $79K | +$86.1K | +38 | New |
|
|
7
Citadel Advisors
Miami,
Florida
| $73K | +$79.3K | +35 | New |
|
|
HF
8
HRT Financial
New York
| $42K | +$45.3K | +20 | New |
|
9
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $32K | – | – | – |
|
10
Morgan Stanley
New York
| $15K | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $8K | – | – | – |
|
|
TC
12
Truvestments Capital
Sarasota,
Florida
| $4K | -$2.27K | -1 | -33% |
|
|
ECM
13
Endurant Capital Management
San Mateo,
California
| – | -$382K | -258 | Closed |
|
|
14
HighTower Advisors
Chicago,
Illinois
| – | -$49K | -33 | Closed |
|
|
15
UBS Group
Zurich,
Switzerland
| – | -$3K | -2 | Closed |
|
AKTX Hedge Fund Activity: Q1 2021 in Review
12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q1 2021, worth a combined $3.9M — up 33% from $2.93M a quarter earlier.
Fund positioning in AKTX was balanced in Q1 2021: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $86.1K. The largest seller was Endurant Capital Management, exiting entirely with an estimated $382K sold.
- 12 institutional investors held Akari Therapeutics (AKTX) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $3.9M of Akari Therapeutics stock for Q1 2021, up 33% quarter-over-quarter.
- 3 funds opened new Akari Therapeutics positions in Q1 2021 and 3 closed out, a net change of 0 holders.
- The largest Akari Therapeutics buyer in Q1 2021 was Geode Capital Management, an estimated $86.1K added.
- The largest Akari Therapeutics seller in Q1 2021 was Endurant Capital Management, an estimated $382K sold.
Based on aggregated 13F filings for Q1 2021.